申请人:McNeilab, Inc.
公开号:US04649204A1
公开(公告)日:1987-03-10
Dialkanolamines and nontoxic pharmaceutically-acceptable acid-addition salts of the compounds of the following formula ##STR1## wherein R.sub.1 is hydrogen lower alkyl, or fluoro; R.sub.2 is hydrogen or lower alkyl; R.sub.3 and R.sub.4 are the same or different and selected from the group consisting of hydrogen or lower alkyl or R.sub.3 and R.sub.4 together define a chemical bond directly linking the two alkanol chains so as to form a pyrrolidine ring; Ar, is phenyl or thienyl or phenyl substituted with one to three substituents selected from the group consisting of lower alkyl and halo; and Ar.sub.2 is phenyl and phenyl substituted with one to three substituents selected from the group consisting of lower alkyl and halo which have antidepressant activity.
二元醇胺和上述结构式中化合物的无毒药物可接受酸加成盐,其中R1为氢、低碳基或氟;R2为氢或低碳基;R3和R4相同或不同,选自氢或低碳基,或R3和R4共同定义化学键,直接连接两个烷醇链以形成吡咯烷环;Ar为苯基或噻吩基或苯基,其中选择一到三个取代基,选自低碳基和卤素;Ar2为苯基和苯基,其中选择一到三个取代基,选自低碳基和卤素,具有抗抑郁活性。